Viewing Study NCT05310734


Ignite Creation Date: 2025-12-25 @ 2:37 AM
Ignite Modification Date: 2025-12-26 @ 1:15 AM
Study NCT ID: NCT05310734
Status: RECRUITING
Last Update Posted: 2025-02-14
First Post: 2022-03-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies
Sponsor: Cipher Pharmaceuticals Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: SPN-110-21
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None INDUSTRY View
None INDUSTRY View
None UNKNOWN View
None UNKNOWN View